GLP-1 Agonists (Ozempic, Wegovy) and Erectile Function
By John K. Matsuura, MD | Medically Reviewed by Christopher W. Boelter, MD |Last updated 20 January 2026 In 2026, GLP-1 receptor agonists such as semaglutide have transformed the management of obesity and metabolic disease. Medications commonly known as Ozempic and Wegovy are now widely prescribed not only for type 2 diabetes but also for long-term weight reduction. As their use […]
GLP-1 Agonists (Ozempic, Wegovy) and Erectile Function Read More »